Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
Change in Working Capital history
Currency unavailable · from the cash flow
No Change in Working Capital data reported for this period type.
Change in Working Capital vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $112.89M USD | +155.6% | — | 9.9% | |
| LTM Mar 2026 | $89.43M USD | +79.1% | +53.1% | 24.8% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 39.64M SEK | +63.6% | — | 2980.4% |
| LTM Mar 2026 | $2.69M USD | -83.4% | +25.9% | 2.3% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | +71.4% | +39.5% | 17.4% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.